Is rechallenge appropriate in patients that develop immune checkpoint inhibitor-associated AKI? PRO
This is an Early Access article. Please select the PDF button, above, to view it. Be sure to also read the CON: 10.34067/KID.0003902021 and the COMMENTARY 10.34067/KID.0005592021
Keyword(s):